Venture startup

Who invested in Elixiron Immunotherapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2025, from 1 source

Latest round
VentureJun 2025
Investors
1
See who backed them

The rounds

  1. Jun 2025
    VentureAmount undisclosed

    Source recorded

Everyone who backed them

Taiwania CapitalGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Elixiron Immunotherapeutics

Who invested in Elixiron Immunotherapeutics?

Elixiron Immunotherapeutics's investors include Taiwania Capital.

How much has Elixiron Immunotherapeutics raised?

Elixiron Immunotherapeutics has raised 1 round since 2025, none with a disclosed amount.

When did Elixiron Immunotherapeutics last raise?

Elixiron Immunotherapeutics's most recent round was a Venture in Jun 2025.

Who backed Elixiron Immunotherapeutics first?

Elixiron Immunotherapeutics's first round on record, in Jun 2025, was backed by Taiwania Capital.

What stage is Elixiron Immunotherapeutics at?

Elixiron Immunotherapeutics's latest named round is a Venture, in Jun 2025.

Companies like Elixiron Immunotherapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.